期刊文献+

C反应蛋白水平及血尿酸浓度与进展性脑卒中相关性分析 被引量:2

Correlation analysis among C reactive protein level,blood uric acid concentration and progressive ischemic stroke
下载PDF
导出
摘要 目的研究进展性脑卒中C反应蛋白(CRP)水平及血尿酸浓度与进展性脑卒中的关系。方法对57例进展性脑卒中患者血浆中CRP及血尿酸进行监测。结果进展性脑卒中患者血浆中CRP水平、血尿酸浓度明显升高,二者与患者神经功能缺损严重程度呈显著正相关。结论血浆CRP水平及血尿酸浓度是临床评价进展性脑卒中病情发展程度和预后的重要指标,可作为急性进展性脑梗死预后的预测指标。 Objective It is to investigate the relationship between the C reactive protein level, the blood uric acid concen- tration and the progressive ischemic stroke. Methods The serous C reactive protein and the blood uric acid of 57 patients with progressive ischemic stroke were monitored. Results The level of C reactive protein and concentration of blood uric acid in patients with progressive ischemic stroke were notably increased, which was closely related to the severity of their neurologic impairment. Conclusion The data of C reactive protein level and blood uric acid concentration is an important clinic measure to estimate the evolution and prognosis of progressive ischemic stroke, it can work as the index of prognosticate the acute evolving of cerebral infarction.
出处 《现代中西医结合杂志》 CAS 2010年第6期664-665,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 脑卒中 C反应蛋白 血尿酸 stroke C reactive protein blood uric acid
  • 相关文献

参考文献10

  • 1BarberM, Langhome P, Rumley A, et al. Hemostatic function and progressing ischem ic stroke: D- dimer predicts early clinical progression[J]. Stroke,2004,35(6) : 1421 - 1425.
  • 2Verma S, LiS H,Badiwala MV, et al. Endothelin antagonism and interleukin- 6 inhibition attenuate the proatherogenic effects of Creactive protein[J]. Circulation,2002,105(16) : 1890 1896.
  • 3Ross R. Atherosclerosis-an inflammatory disease[ J ]. N Engl J Med, 1999,340(2) :115 - 126.
  • 4Li JJ, Fang CH. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular disease [ J J. Med Hypotheses,2004,62(4) :499- 506.
  • 5lyigun I, Baklrci Y. Plasma concentrations of C- reactive protein and fibrinogen in ischemic stroke[J ]. lnt Med Res, 2002,30(6) :591 - 596.
  • 6Muir KW, Weri CJ, Alwan W, et al. C-reactive protein and out come after after ischemic stroke[J ]. Stroke, 1999,30 (5) :981 - 985.
  • 7曹红,孙长凯,赵耿毅,汪秋艳,刘新胜,许晶,陶定波,唐树良,黄爱莉.C-反应蛋白水平与脑梗死病情及预后的量化研究[J].中国现代神经疾病杂志,2005,5(2):84-87. 被引量:34
  • 8Dirnagl U, ladecola C, Moskowitz MA. Pathobiology of ischemic stroke: an integrated rview [ J ]. Trends Neurosci, 1999,22 ( 4 ) : 391 - 397.
  • 9王爱华,孙华,孙钦建,刘小民,张秀清,迟兆富.血浆尿酸水平对急性卒中后病人远期预后的影响[J].中华神经医学杂志,2007,6(6):557-560. 被引量:12
  • 10陈立杰,李和永.高尿酸血症与缺血性卒中[J].国际脑血管病杂志,2006,14(12):922-924. 被引量:27

二级参考文献38

  • 1吴丽娥,刘鸣,张月辉,赵晓玲,杨杰,谈颂,张世洪,吴波,谭燕,王清芳,王丽春,李伟.缺血性脑卒中TOAST病因分型和预后[J].中华神经科杂志,2004,37(4):292-295. 被引量:87
  • 2叶任高.内科学(第五版)[M].北京:人民卫生出版社,2001.27.
  • 3[3]Dziedzic T, Gryz EA, Turaj W, et al. Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients. J Mol Neurosci, 2004, 24:293-298.
  • 4[4]Silvestri A, Vitale C, Ferretti F, et al. Plasma levels of inflammatory C-reactive protein and interleukin-6 predict outcome in elderly patients with stroke. J Am Geriatr Soc, 2004, 52:1586-1587.
  • 5[5]Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke, 2001, 32:917-924.
  • 6[6]Muir KW, Weir CJ, Alwan W, et al. C-reactive protein and outcome after ischemic stroke. Stroke, 1999, 30:981-985.
  • 7[7]Chan Carusone S, Smieja M, Molloy W, et al. Lack of association between vascular dementia and Chlamydia pneumoniae infection: a case-control study. BMC Neurol, 2004, 4:15.
  • 8[8]Van Der Meer IM, De Maat MP, Hak AE, et al. C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study. Stroke, 2002, 33:2750-2755.
  • 9[9]Hashimoto H, Kitagawa K, Hougaku H, et al. Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects. Stroke, 2004, 35:1625-1630.
  • 10[10]Patrick L, Uzick M. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols: A review of the literature. Altern Med Rev, 2001, 6:248-271.

共引文献66

同被引文献20

  • 1曹红,孙长凯,赵耿毅,汪秋艳,刘新胜,许晶,陶定波,唐树良,黄爱莉.C-反应蛋白水平与脑梗死病情及预后的量化研究[J].中国现代神经疾病杂志,2005,5(2):84-87. 被引量:34
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33022
  • 3吴锋,马西,庄贵华,车金.一种总体止血能力的检测方法及其应用[J].血栓与止血学,2007,13(3):109-112. 被引量:8
  • 4Folsom AR.Hemostatic risk factors for atherothrombotic disease:an epidemiologic view.Thromb Haemost,2001,86:366-373.
  • 5Doyle KP,Simon RP,Stenzel-Poore MP.Mechanisms of ischemic brain damage.Neuropharmacology,2008,55:310-318.
  • 6He S,Bremme K,Blombck M.A laboratory method for determination of overall haemostatic potential in plasma.I.Method design and preliminary result.Thromb Res,1999,96:145-156.
  • 7Antovic A.Screening haemostasis--looking for global assays:the Overall Haemostasis Potential (OHP) method--a possible tool for laboratory investigation of global haemostasis in both hypo-and hypercoagulable conditions.Curr Vasc Pharmacol,2008,6:173-185.
  • 8Antovic A,Blombck M,Sten-Linder M,et al.Identifying hypocoagulable states with a modified global assay of overall haemostasis potential in plasma.Blood Coagul Fibrinolysis,2005,16:585-596.
  • 9Iyigün I,Bakirci Y.Plasma concentrations of C-reactive protein and fibrinogen in ischaemic stroke.J Int Med Res,2002,30:591-596.
  • 10del Zoppo GJ,Levy DE,Wasiewski WW,et al.Hyperfibrinogenemia and functional outcome from acute ischemic stroke.Stroke,2009,40:1687-1691.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部